Press Releases

Deerfield Management and Deerfield Foundation Announce Second Annual AML Summit and Recipients of American Society of Hematology (ASH) Peter Steelman Scholar Award

Deerfield names two healthcare leaders as latest recipients of the ASH Peter Steelman Scholar Award

Genscience and Deerfield Management Announce Nature Publication Reporting Positive Impact of Genetic Evidence to Aid Discovery of More Effective Drug Targets

Cure opens XSeed Awards to Support Underfunded and Underrepresented NYC Life Science Startups with up to $500,000

Washington University and Deerfield Management Launch VeritaScience to Drive Drug Discovery

Deerfield Management makes 10-year commitment of up to $130 million to accelerate translation of Washington University discoveries to improve human health

Deerfield Foundation Awards More Than $1.4 Million to Improve Health, Accelerate Innovation and Promote Equity

13 organizations in seven countries to receive support for projects focused on children, spanning development and delivery of treatments to public health improvements

Sfunga Therapeutics and Deerfield Management Announce Publication on Novel Antifungal SF001 in Nature

– SF001, with QIDP and FDA Fast Track designations, in Phase 1 clinical development –

Deerfield Management and the Deerfield Foundation Announce the Creation of the American Society of Hematology (ASH) Peter Steelman Scholar Award and the First Annual AML Summit to Advance Research for Acute Myeloid Leukemia

NYU Langone Health and Deerfield Management Launch Amethyst Innovations with Up To $130 Million to Accelerate Commercialization of Biomedical Discoveries

Researchers at NYU Langone will gain access to Deerfield Management's capital, infrastructure, and specialized resources to help advance novel therapeutics beyond the lab.

Deerfield Management Announces 2023 XSeed Award Winners

Two Minority-Led Life Science Startup Companies Awarded $250,000 Grants and Access to Cure® Ecosystem

Deerfield Management Announces $25M Grant from New York State and Empire State Development to Build a Lab of the Future at Healthcare Innovation Campus, Cure®

• Next-generation laboratory will leverage AI and ML to drastically improve speed, accuracy, and cost of drug development

Invitae and Deerfield Management Partner to Create Novel Therapeutics for Rare Diseases

– The partnership will harness genetic and clinical data from millions of patients tested at Invitae and Deerfield's expertise in drug discovery to address high unmet needs among rare disease patients –

Cold Spring Harbor Laboratory and Deerfield Management Launch Harbor Discoveries to Advance New Therapeutics

Deerfield commits up to $130 million over 10 years to support drug development efforts